Slow Re-opening

The tuberculosis lab at the US Centers for Disease Control and Prevention is set to re-open, the New York Times reports.

The lab, along with others at the agency, was closed earlier this month following the mishandling of the anthrax and H5N1 influenza viruses in incidents that exposed CDC personnel to the infectious agents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.